Severe Alzheimer's Disease

Treatment Effects on Function and Care Requirements

Diana Kerwin, Thomas H. Claus

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

The number and age of patients with Alzheimer's disease (AD) continues to increase dramatically with more patients requiring long-term skilled care. The care of patients with AD, particularly those with severe AD, is a challenge that long-term care administrators are facing with increasing frequency. The therapeutic approach to patients in the moderate to severe stages of AD is a combination of pharmacologic agents to maximize patient function and independence and is cost effective for the nursing home facility and the patient. Here we review the use of drug therapy in patients with severe AD, focusing on function and long-term care perspectives.

Original languageEnglish (US)
Pages (from-to)99-104
Number of pages6
JournalJournal of the American Medical Directors Association
Volume12
Issue number2
DOIs
StatePublished - Feb 1 2011

Fingerprint

Alzheimer Disease
Long-Term Care
Therapeutics
Nursing Homes
Administrative Personnel
Patient Care
Costs and Cost Analysis
Drug Therapy

Keywords

  • Alzheimer's disease
  • Cholinesterase inhibitors
  • Function
  • Memantine

ASJC Scopus subject areas

  • Medicine(all)
  • Nursing(all)
  • Health Policy

Cite this

Severe Alzheimer's Disease : Treatment Effects on Function and Care Requirements. / Kerwin, Diana; Claus, Thomas H.

In: Journal of the American Medical Directors Association, Vol. 12, No. 2, 01.02.2011, p. 99-104.

Research output: Contribution to journalReview article

@article{fd64fa53a02a45fe9738adc8fd3c7ae3,
title = "Severe Alzheimer's Disease: Treatment Effects on Function and Care Requirements",
abstract = "The number and age of patients with Alzheimer's disease (AD) continues to increase dramatically with more patients requiring long-term skilled care. The care of patients with AD, particularly those with severe AD, is a challenge that long-term care administrators are facing with increasing frequency. The therapeutic approach to patients in the moderate to severe stages of AD is a combination of pharmacologic agents to maximize patient function and independence and is cost effective for the nursing home facility and the patient. Here we review the use of drug therapy in patients with severe AD, focusing on function and long-term care perspectives.",
keywords = "Alzheimer's disease, Cholinesterase inhibitors, Function, Memantine",
author = "Diana Kerwin and Claus, {Thomas H.}",
year = "2011",
month = "2",
day = "1",
doi = "10.1016/j.jamda.2010.06.011",
language = "English (US)",
volume = "12",
pages = "99--104",
journal = "Journal of the American Medical Directors Association",
issn = "1525-8610",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Severe Alzheimer's Disease

T2 - Treatment Effects on Function and Care Requirements

AU - Kerwin, Diana

AU - Claus, Thomas H.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - The number and age of patients with Alzheimer's disease (AD) continues to increase dramatically with more patients requiring long-term skilled care. The care of patients with AD, particularly those with severe AD, is a challenge that long-term care administrators are facing with increasing frequency. The therapeutic approach to patients in the moderate to severe stages of AD is a combination of pharmacologic agents to maximize patient function and independence and is cost effective for the nursing home facility and the patient. Here we review the use of drug therapy in patients with severe AD, focusing on function and long-term care perspectives.

AB - The number and age of patients with Alzheimer's disease (AD) continues to increase dramatically with more patients requiring long-term skilled care. The care of patients with AD, particularly those with severe AD, is a challenge that long-term care administrators are facing with increasing frequency. The therapeutic approach to patients in the moderate to severe stages of AD is a combination of pharmacologic agents to maximize patient function and independence and is cost effective for the nursing home facility and the patient. Here we review the use of drug therapy in patients with severe AD, focusing on function and long-term care perspectives.

KW - Alzheimer's disease

KW - Cholinesterase inhibitors

KW - Function

KW - Memantine

UR - http://www.scopus.com/inward/record.url?scp=78751704131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751704131&partnerID=8YFLogxK

U2 - 10.1016/j.jamda.2010.06.011

DO - 10.1016/j.jamda.2010.06.011

M3 - Review article

VL - 12

SP - 99

EP - 104

JO - Journal of the American Medical Directors Association

JF - Journal of the American Medical Directors Association

SN - 1525-8610

IS - 2

ER -